[Bronchodilating effect of Berotec in bronchial asthma]. 1974

T Adamek, and G Czerniawska-Mysik, and A Szczeklik

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009921 Metaproterenol A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM. Orciprenaline,Alotec,Alupent,Astmopent,Metaprel,Metaproterenol Polistirex,Metaproterenol Sulfate,Orciprenaline Sulfate,Polistirex, Metaproterenol
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D001993 Bronchodilator Agents Agents that cause an increase in the expansion of a bronchus or bronchial tubes. Bronchial-Dilating Agents,Bronchodilator,Bronchodilator Agent,Broncholytic Agent,Bronchodilator Effect,Bronchodilator Effects,Bronchodilators,Broncholytic Agents,Broncholytic Effect,Broncholytic Effects,Agent, Bronchodilator,Agent, Broncholytic,Agents, Bronchial-Dilating,Agents, Bronchodilator,Agents, Broncholytic,Bronchial Dilating Agents,Effect, Bronchodilator,Effect, Broncholytic,Effects, Bronchodilator,Effects, Broncholytic
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females

Related Publications

T Adamek, and G Czerniawska-Mysik, and A Szczeklik
February 1987, JAMA,
T Adamek, and G Czerniawska-Mysik, and A Szczeklik
November 1993, Ugeskrift for laeger,
T Adamek, and G Czerniawska-Mysik, and A Szczeklik
January 1981, Pneumonologia polska,
T Adamek, and G Czerniawska-Mysik, and A Szczeklik
February 1993, Annals of allergy,
T Adamek, and G Czerniawska-Mysik, and A Szczeklik
April 1983, Casopis lekaru ceskych,
T Adamek, and G Czerniawska-Mysik, and A Szczeklik
February 1990, Chest,
T Adamek, and G Czerniawska-Mysik, and A Szczeklik
January 1986, Sovetskaia meditsina,
T Adamek, and G Czerniawska-Mysik, and A Szczeklik
January 1987, Acta physiologica Hungarica,
T Adamek, and G Czerniawska-Mysik, and A Szczeklik
January 1998, Klinicheskaia meditsina,
T Adamek, and G Czerniawska-Mysik, and A Szczeklik
January 1994, Ugeskrift for laeger,
Copied contents to your clipboard!